Mental Health Clinics in Burlington, IA Accepting Medicare
13 Mental Health Clinics found. Showing 1 - 13
 Therapy Group, Inc. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1408 N Central Ave, Burlington, IA 52601 Phone: 319-208-1650 |
Young House Family Services Inc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 400 S Broadway St, Burlington, IA 52601 Phone: 319-752-4000 Fax: 319-752-6933 |
Young House Family Services, Incorporated Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4717 Sullivan Slough Rd, Burlington, IA 52601 Phone: 319-758-4000 Fax: 319-752-6933 |
O'rourke, Grinstead, Pierce & Associates Social Worker Medicare: Not Enrolled in Medicare Practice Location: 610 N 4th St Ste 110, Burlington, IA 52601 Phone: 319-754-8035 Fax: 319-754-9213 |
Alcohol & Drug Dependency Services Of Se Iowa Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1340 Mt. Pleasant St, Burlington, IA 52601 Phone: 317-753-6567 Fax: 319-753-0703 |
Innovative Family Therapy & Play Therapy Center Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 409 N 4th St Ste 108, Burlington, IA 52601 Phone: 319-759-9414 |
Rescare, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 407 N 4th St, Burlington, IA 52601 Phone: 319-754-4618 Fax: 319-754-4193 |
Family Behavioral Healthcare Of Iowa Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 218 N 3rd St, Suite 600, Burlington, IA 52601 Phone: 319-752-7300 Fax: 319-752-4255 |
Clarity Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 312 Lewis St, Burlington, IA 52601 Phone: 309-740-8056 |
Young House Family Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 4717 Sullivan Slough Rd, Burlington, IA 52601 Phone: 319-752-8095 Fax: 319-758-5217 |
Young House Family Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 724 N 3rd St, Burlington, IA 52601 Phone: 319-752-4000 |
The O'rourke Group, Pc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 610 N 4th St, Suite 110a, Burlington, IA 52601 Phone: 319-754-8035 Fax: 319-754-9213 |
Sunrise Enterprise Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 606 Spring St, Burlington, IA 52601 Phone: 319-753-2400 Fax: 319-753-2400 |
News Archive
Research provides promising new lead for schizophrenia treatment
Schizophrenia is a severe mental health condition that causes significant disability, and affects 1 in 100 people. Patients with schizophrenia commonly experience negative symptoms, which include lack of motivation, social isolation and inability to experience pleasurable feeling.
Study reveals how interneurons emerge and diversify in the brain
Modern neuroscience, for all its complexity, can trace its roots directly to a series of pen-and-paper sketches rendered by Nobel laureate Santiago Ramón y Cajal in the late 19th and early 20th centuries.
Merge Healthcare subsidiary extends tender offer period for AMICAS shares
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
Carboplatin and paclitaxel show promise for advanced thymic carcinoma
A multicentre, phase II study of carboplatin and paclitaxel in chemotherapy-naïve patients with advanced thymic carcinoma has shown that the treatment has promising efficacy compared with standard anthracycline-based chemotherapy.
Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients
Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.
› Verified 6 days ago